Attributes for a discrete-choice experiment on preferences of patients for oncology pharmacy consultations
- PMID: 38687392
- DOI: 10.1007/s00520-024-08517-z
Attributes for a discrete-choice experiment on preferences of patients for oncology pharmacy consultations
Abstract
Purpose: To ensure the safe use of oral anticancer drugs, oncology pharmacy consultations (OPCs) have been established in France. They are conditioned by the needs, expectations, and involvement of the patients in their care. Thus, it is essential to elicit their preferences. The discrete-choice experiment (DCE) is a method recommended by the ISPOR for such a task. The "selection and validation of attributes and their values" step is fundamental in this process. In this context, the aim of this study was to present our research approach to identify and validate the attributes that characterize an OPC and their values.
Methods: Due to the lack of relevant published data in the literature, the focus-group method was used in accordance with good research practices for the application of conjoint-analysis of the ISPOR. The two-round Delphi method was used to validate the attributes and their values identified by the focus-group method.
Results: The focus-group method enabled identification of nine attributes. Thirty-seven healthcare professionals at a national level, including 30 pharmacists and seven physicians, were selected to take part in the Delphi procedure. Seven attributes (frequency, planification, operation mode, duration, content, written support, and report) and their values were thus validated.
Conclusion: Based on these results, the next step will be to elicit patient preferences for OPCs and to then shed light on the issues of pharmaceutical support for patients by comparing their preferences with those of informal caregivers and, in particular, those of the healthcare professionals involved in their care.
Keywords: Delphi method; Discrete-choice experiment; Oncology pharmacy consultation; Patient healthcare; Preferences.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- The French National Cancer Institute - www.en.ecancer.fr . https://en.e-cancer.fr/ . Accessed 25 Apr 2024
-
- Lasala R, Santoleri F (2022) Association between adherence to oral therapies in cancer patients and clinical outcome: a systematic review of the literature. Br J Clin Pharmacol 88(5):1999–2018. https://doi.org/10.1111/bcp.15147 - DOI - PubMed
-
- Petit-Jean E, Correard F, Maillan G et al (2019) Pharmaceutical consultations in oncology: French Society for Oncology Pharmacy (Société Francaise de Pharmacie Oncologique – SFPO) guidelines. Eur J Oncol Pharm 2(2):e11. https://doi.org/10.1097/OP9.0000000000000011 - DOI
-
- Moumjid N, Nguyen F, Bremond A et al (2008) Patients’ preferences and decision-making: state of the art and applications in cancer. Rev Epidemiol Sante Publique 56(Suppl 3):S231-238. https://doi.org/10.1016/j.respe.2008.04.008 - DOI - PubMed
-
- Bastiaens H, Van Royen P, Pavlic DR, Raposo V, Baker R (2007) Older people’s preferences for involvement in their own care: a qualitative study in primary health care in 11 European countries. Patient Educ Couns 68(1):33–42. https://doi.org/10.1016/j.pec.2007.03.025 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
